NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $476,000 | -81.7% | 13,956 | -74.1% | 0.00% | -83.3% |
| Q3 2021 | $2,603,000 | +122.9% | 53,968 | +108.8% | 0.01% | +100.0% |
| Q2 2021 | $1,168,000 | -80.6% | 25,850 | -79.3% | 0.00% | -78.6% |
| Q1 2021 | $6,010,000 | -22.9% | 124,600 | -14.0% | 0.01% | -12.5% |
| Q4 2020 | $7,796,000 | +312.1% | 144,800 | +182.3% | 0.02% | +220.0% |
| Q3 2020 | $1,892,000 | +91.1% | 51,300 | +60.5% | 0.01% | +66.7% |
| Q2 2020 | $990,000 | +53.7% | 31,962 | +37.2% | 0.00% | -25.0% |
| Q1 2020 | $644,000 | -27.7% | 23,290 | -23.6% | 0.00% | 0.0% |
| Q4 2019 | $891,000 | +84.1% | 30,473 | +20.5% | 0.00% | +33.3% |
| Q3 2019 | $484,000 | -75.3% | 25,293 | -71.7% | 0.00% | -76.9% |
| Q2 2019 | $1,963,000 | +209.1% | 89,496 | +188.3% | 0.01% | +225.0% |
| Q1 2019 | $635,000 | +247.0% | 31,048 | +113.7% | 0.00% | +300.0% |
| Q4 2018 | $183,000 | -78.8% | 14,532 | -74.2% | 0.00% | -66.7% |
| Q3 2018 | $865,000 | – | 56,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |